Blackstone related stories
All articles and analysis
Why Bouwinvest joined Blackstone's BioMed rollover fundLooking to grow its exposure to niche property types, the new open-end life science real estate fund was too good for the Dutch pension investor pass up.
Yardi: Proptech holds the keyCutting-edge tools and enterprise-grade proptech hold the key to managing rapid change, say Yardi Systems’ Robert Teel, senior vice-president, global solutions and Chris Barbier, industry principal, investment management
AXA’s O’Driscoll: €500m life science deal ‘not a reaction to covid-19'The head of European transactions at the real assets business of French insurer AXA says the deal to acquire Kadans Science Partner is the outcome of interest in the sector that started more than a year ago.
Blueprint: Tishman Speyer's new global aspiration, the big banks backing student housing, Korean investors in the USTishman Speyer's global aspirations for life science real estate; Korean investors' renewed love for US real estate; Harrison Street's student housing credit extension; and more in today's briefing, exclusively for our valued subscribers.
Tishman Speyer-backed life science fund raises $1bnWith $500m in its debut fund and $500m in co-invest capital, Breakthrough Properties aims to take life science real estate investment global.
Why Blackstone’s latest logistics play is a rarity in ChinaThe seller R&F group will use part of the $1.1bn in proceeds to pay its debt under the ‘three red lines’ policy introduced by the Chinese government.
What a Biden presidency means for private real estateWhile a divided government rules out the president-elect’s tax plan, ESG strategies and health and life science real estate are likely to prosper.
Blueprint: Colony's new CEO on politics, China's three red lines, Airbnb's upcoming IPO, Brookfield's latest rescueWhy Colony Capital's Marc Ganzi is steering clear of politics; how China's new regulation of housing developers is impacting other property types; what Brookfield and Simon are hoping for from JC Penney; and more in today's briefing, exclusively for our valued subscribers.
Pfizer’s vaccine update is a nudge, at best, to private real estateThe sector’s reaction to the news of an effective covid-19 treatment has not been as exuberant as that of the public markets.
Blueprint: What a Biden presidency means for private real estate; California, Florida pensions join URW coup; Investcorp capitalizes on sellers' marketWhat a Joe Biden presidency might look like for private real estate; Investcorp's $900m multifamily exit; CalPERS and the State Board of Administration of Florida back Aermont's Bressler and company in REIT takeover; and more in today's briefing, exclusively for our valued subscribers.